1. Home
  2. PAHC vs XPRO Comparison

PAHC vs XPRO Comparison

Compare PAHC & XPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • XPRO
  • Stock Information
  • Founded
  • PAHC 1946
  • XPRO 1938
  • Country
  • PAHC United States
  • XPRO United States
  • Employees
  • PAHC N/A
  • XPRO N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • XPRO Oilfield Services/Equipment
  • Sector
  • PAHC Health Care
  • XPRO Energy
  • Exchange
  • PAHC Nasdaq
  • XPRO Nasdaq
  • Market Cap
  • PAHC 1.5B
  • XPRO 1.5B
  • IPO Year
  • PAHC 2014
  • XPRO 2013
  • Fundamental
  • Price
  • PAHC $44.48
  • XPRO $13.40
  • Analyst Decision
  • PAHC Hold
  • XPRO Buy
  • Analyst Count
  • PAHC 4
  • XPRO 4
  • Target Price
  • PAHC $31.25
  • XPRO $14.00
  • AVG Volume (30 Days)
  • PAHC 324.6K
  • XPRO 1.3M
  • Earning Date
  • PAHC 11-05-2025
  • XPRO 10-23-2025
  • Dividend Yield
  • PAHC 1.06%
  • XPRO N/A
  • EPS Growth
  • PAHC 288.74
  • XPRO 313.92
  • EPS
  • PAHC 1.67
  • XPRO 0.59
  • Revenue
  • PAHC $1,399,676,000.00
  • XPRO $1,661,811,000.00
  • Revenue This Year
  • PAHC $14.80
  • XPRO N/A
  • Revenue Next Year
  • PAHC $3.16
  • XPRO $2.88
  • P/E Ratio
  • PAHC $27.13
  • XPRO $22.42
  • Revenue Growth
  • PAHC 33.72
  • XPRO N/A
  • 52 Week Low
  • PAHC $16.16
  • XPRO $6.70
  • 52 Week High
  • PAHC $46.42
  • XPRO $14.97
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 62.55
  • XPRO 50.73
  • Support Level
  • PAHC $43.71
  • XPRO $13.15
  • Resistance Level
  • PAHC $44.00
  • XPRO $14.23
  • Average True Range (ATR)
  • PAHC 2.15
  • XPRO 0.63
  • MACD
  • PAHC 0.08
  • XPRO -0.08
  • Stochastic Oscillator
  • PAHC 73.40
  • XPRO 38.36

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About XPRO Expro Group Holdings N.V.

Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.

Share on Social Networks: